Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 10,732Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Rexulti

02 7Rexulti/Rxulti

03 5Rexulti/Rxulti

PharmaCompass

01

Brand Name : Rexulti/Rxulti

Brexpiprazole

arrow
APS Symposium
Not Confirmed

Brand Name : Rexulti/Rxulti

arrow
APS Symposium
Not Confirmed

Brexpiprazole

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 993

2019 Revenue in Millions : 853

Growth (%) : 16

blank

02

Brand Name : Rexulti/Rxulti

Brexpiprazole

arrow
APS Symposium
Not Confirmed

Brand Name : Rexulti/Rxulti

arrow
APS Symposium
Not Confirmed

Brexpiprazole

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 426

2019 Revenue in Millions : 369

Growth (%) : 15

blank

03

Brand Name : Rexulti/Rxulti

Brexpiprazole

arrow
APS Symposium
Not Confirmed

Brand Name : Rexulti/Rxulti

arrow
APS Symposium
Not Confirmed

Brexpiprazole

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 1,022

2020 Revenue in Millions : 953

Growth (%) : 16

blank

04

Brand Name : Rexulti/Rxulti

Brexpiprazole

arrow
APS Symposium
Not Confirmed

Brand Name : Rexulti/Rxulti

arrow
APS Symposium
Not Confirmed

Brexpiprazole

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 434

2020 Revenue in Millions : 419

Growth (%) : 9

blank

05

Brand Name : Rexulti/Rxulti

Brexpiprazole

arrow
APS Symposium
Not Confirmed

Brand Name : Rexulti/Rxulti

arrow
APS Symposium
Not Confirmed

Brexpiprazole

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 560

2021 Revenue in Millions : 434

Growth (%) : 29

blank

06

Brand Name : Rexulti/Rxulti

Brexpiprazole

arrow
APS Symposium
Not Confirmed

Brand Name : Rexulti/Rxulti

arrow
APS Symposium
Not Confirmed

Brexpiprazole

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 1,278

2021 Revenue in Millions : 1,022

Growth (%) : 25

blank

07

Brand Name : Rexulti/Rxulti

Brexpiprazole

arrow
APS Symposium
Not Confirmed

Brand Name : Rexulti/Rxulti

arrow
APS Symposium
Not Confirmed

Brexpiprazole

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 652

2022 Revenue in Millions : 560

Growth (%) : 16

blank

08

Brand Name : Rexulti/Rxulti

Brexpiprazole

arrow
APS Symposium
Not Confirmed

Brand Name : Rexulti/Rxulti

arrow
APS Symposium
Not Confirmed

Brexpiprazole

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 1,417

2022 Revenue in Millions : 1,278

Growth (%) : 26

blank

09

Brand Name : Rexulti/Rxulti

Brexpiprazole

arrow
APS Symposium
Not Confirmed

Brand Name : Rexulti/Rxulti

arrow
APS Symposium
Not Confirmed

Brexpiprazole

Main Therapeutic Indication : Neurology

Currency : USD

2024 Revenue in Millions : 721

2023 Revenue in Millions : 652

Growth (%) : 11

blank

10

Brand Name : Rexulti/Rxulti

Brexpiprazole

arrow
APS Symposium
Not Confirmed

Brand Name : Rexulti/Rxulti

arrow
APS Symposium
Not Confirmed

Brexpiprazole

Main Therapeutic Indication : Neurology

Currency : USD

2024 Revenue in Millions : 1,741

2023 Revenue in Millions : 1,417

Growth (%) : 23

blank